Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
In the last 90 days, Protara Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Protara Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −10 vs. Q1 2021
- Shares held
- 7.11M
- −1.42M (−16.6%) vs. Q1 2021
- Total value
- $69.3M
- −$64.8M (−48.3%) vs. Q1 2021
- New holders
- 9
- 8 more added
- Sold out
- 19
- 18 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| New York State Common Retirement Fund | 29 | $0 | 0.00% | −3,171−99.1% | Reduced |
| Citigroup Inc | 15 | $0 | 0.00% | −242−94.2% | Reduced |
| Panagora Asset Management Inc | 55 | $1.00K | 0.00% | −5,866−99.1% | Reduced |
| UBS Group AG | 99 | $1.00K | 0.00% | −1,338−93.1% | Reduced |
| JPMorgan Chase & Co | 177 | $2.00K | 0.00% | −1,376−88.6% | Reduced |
| Simplex Trading, LLC | 581 | $5.00K | 0.00% | +581 | New |
| Retirement Group, LLC | 500 | $5.00K | 0.00% | +500 | New |
| Wells Fargo & Company | 559 | $6.00K | 0.00% | −67,733−99.2% | Reduced |
| Bank of America Corp | 932 | $9.00K | 0.00% | −3,168−77.3% | Reduced |
| Tower Research Capital LLC (TRC) | 1,548 | $15.0K | 0.00% | −180−10.4% | Reduced |
| State Street Corp | 10,359 | $101.0K | 0.00% | −49,774−82.8% | Reduced |
| Prelude Capital Management, LLC | 11,700 | $114.0K | 0.01% | +11,700 | New |
| HRT Financial LP | 12,151 | $118.0K | 0.00% | +12,151 | New |
| Jane Street Group, LLC | 13,678 | $133.0K | 0.00% | +13,678 | New |
| Marshall Wace, LLP | 17,469 | $170.0K | 0.00% | −24,667−58.5% | Reduced |
| Ergoteles LLC | 17,700 | $172.0K | 0.00% | +17,700 | New |
| Bank of New York Mellon Corp | 17,907 | $174.0K | 0.00% | −7,778−30.3% | Reduced |
| Susquehanna International Group, LLP | 20,609 | $201.0K | 0.00% | +20,609 | New |
| Northern Trust Corp | 22,279 | $217.0K | 0.00% | −34,397−60.7% | Reduced |
| Schonfeld Strategic Advisors LLC | 24,455 | $238.0K | 0.00% | +1,000+4.3% | Added |
| Knott David M | 36,164 | $352.0K | 0.14% | +21,795+151.7% | Added |
| BlackRock Inc. | 40,125 | $391.0K | 0.00% | −149,751−78.9% | Reduced |
| Morgan Stanley | 48,884 | $475.0K | 0.00% | +47,528+3,505.0% | Added |
| Renaissance Technologies LLC | 51,427 | $501.0K | 0.00% | +20,027+63.8% | Added |
| Two Sigma Investments, LP | 55,405 | $540.0K | 0.00% | +55,405 | New |
| Boothbay Fund Management, LLC | 56,883 | $554.0K | 0.02% | −1,343−2.3% | Reduced |
| Two Sigma Advisers, LP | 58,318 | $568.0K | 0.00% | +46,200+381.3% | Added |
| Geode Capital Management, LLC | 82,985 | $808.0K | 0.00% | −28,077−25.3% | Reduced |
| Millennium Management LLC | 129,380 | $1.26M | 0.00% | +69,246+115.2% | Added |
| Goldman Sachs Group Inc | 132,257 | $1.29M | 0.00% | +132,257 | New |
| Baker Bros. Advisors LP | 199,671 | $1.95M | 0.01% | 00.0% | Unchanged |
| Boxer Capital, LLC | 209,227 | $2.04M | 0.07% | 00.0% | Unchanged |
| Citadel Advisors LLC | 342,021 | $3.33M | 0.00% | +100,507+41.6% | Added |
| Franklin Resources Inc | 350,010 | $3.41M | 0.00% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 421,641 | $4.11M | 0.05% | −10.0% | Reduced |
| Vanguard Group Inc | 437,108 | $4.26M | 0.00% | −19,425−4.3% | Reduced |
| OrbiMed Advisors LLC | 450,000 | $4.38M | 0.04% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 584,804 | $5.70M | 1.02% | −64,738−10.0% | Reduced |
| Rock Springs Capital Management LP | 693,542 | $6.75M | 0.13% | +3,600+0.5% | Added |
| Opaleye Management Inc. | 2,558,472 | $24.9M | 4.14% | 00.0% | Unchanged |
| CBIZ Investment Advisory Services, LLC | 0 | $0 | 0.00% | – | Sold out |
| Artisan Partners Limited Partnership | 0 | $0 | 0.00% | −379,946−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −319,326−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −172,177−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −109,405−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −61,742−100.0% | Sold out |
| Granahan Investment Management Inc | 0 | $0 | 0.00% | −52,026−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −25,185−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −20,279−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −13,940−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −12,060−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −5,851−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −2,480−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −2,254−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −969−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −492−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −178−100.0% | Sold out |